Last reviewed · How we verify

NCT07065474

Effectiveness of Edutainment-Based Interventions in Increasing Knowledge of Rheumatic Fever and Rheumatic Heart Disease Among School-Going Children in Nepal: Study Protocol for Colors to Save Hearts Quasi-Experimental Pretest-Posttest Study

Not yet recruiting NA Last updated 15 July 2025
What this trial tests

NA trial testing education material in Rheumatic Heart Disease in 2,400 participants. Not yet recruiting.

Timeline
28 July 2025
Primary endpoint
3 October 2025
12 November 2025

Quick facts

Lead sponsorKathmandu Institute of Child Health
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment2,400
Start date28 July 2025
Primary completion3 October 2025
Estimated completion12 November 2025
Sites1 location across Nepal

Drugs / interventions tested

Conditions studied

Sponsor

Kathmandu Institute of Child Health

Who can join

Adults 10 to 18, any sex, with Rheumatic Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Acute rheumatic fever (ARF) and its sequela, rheumatic heart disease (RHD), remain significant public health concerns in low- and middle-income countries, including Nepal. Despite their preventable nature, awareness of ARF and RHD among schoolchildren is limited. Innovative, age-appropriate health education strategies are urgently needed to promote early recognition and prevention. Objective: This study aims to evaluate the effectiveness of an edutainment-based intervention in improving knowledge of ARF and RHD among school-going children in Nepal. Methods: A quasi-experimental pretest-posttest study design with a waitlist control group will be employed across 24 public schools in six diverse districts. A total of 2,400 students from Grades 6 to 9 will be included. The intervention integrates creative educational tools-coloring books, activity books, storytelling, videos, and interactive sessions-tailored to different age groups. Knowledge change will be measured using a validated questionnaire administered at baseline and post-intervention. Secondary outcomes include the prevalence of RHD-related symptoms assessed through clinical screening. Expected Outcomes: It is hypothesized that students in the intervention group will demonstrate a statistically significant improvement in knowledge scores compared to their baseline levels and the control group. The study will also assess the feasibility and acceptability of the intervention and inform recommendations for broader school-based health education programs. Conclusion: This study addresses a critical gap in child health education in Nepal using an innovative, scalable approach. Findings will contribute to the evidence base for integrating edutainment into school curricula to combat preventable diseases like RHD in resource-limited settings.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Measuring Children's Knowledge of Acute Rheumatic Fever and Rheumatic Heart Disease: Development and Validation of RHD Knowledge Scale in Nepal.
    Karki S, Paudel S, Hada RP, Khadka P, et al · · 2025 · PMID 41408758 · DOI 10.1177/00469580251405997

Verify or expand the search:

Other recruiting trials for Rheumatic Heart Disease

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07065474.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing